Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Video ▼Online-CME News ▼Meeting Reports Slides ▼About

ACC.19 ▼AHA 2018 ▼Diabetes & CVD ▼EAS 2019 ▼Epigenetics in CVD ▼ESC 2019 ▼Expert Meeting GLP-1, CVD & T2DM ▼HFpEF: The essentials to know ▼Invest in your arteries ▼LDL-c Expert Meeting ▼LDL-c Key Lessons ▼PCSK9 ▼

HoFH

Feb. 8, 2015

Share this page with your colleagues and friends:

Continue reading:

5 Things a cardiologist should know about diabetes

Slide Curriculum: Diabetes and cardiology

Slides (curriculum) - July 24, 2018

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

ACS

A one-hour hs-troponin protocol in ACS suspected patients resulted in more rapid discharge

3' education - Sep. 3, 2019 - Prof. Derek Chew

Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients

3' education - Sep. 3, 2019 - Danny Claassens

Unexpected findings of superiority with a P2Y12 inhibitor in reducing outcomes in ACS patients

Literature - Sep. 1, 2019

Atherosclerosis

Primary and secondary efficacy endpoints met with siRNA against PCSK9

News - Aug. 27, 2019

CAC helps to identify people who will benefit from NOAC for primary prevention of ASCVD

Literature - Aug. 26, 2019 - Arps K et al. - Am J Cardiol 2019

High CAC score associated with increased mortality in young adults

Literature - Aug. 8, 2019 - Miedema MD et al. - JAMA Netw Open 2019

Atrial fibrillation

Clear results with NOAC monotherapy in patients with CAD and AF

3' education - Sep. 2, 2019 - Prof. Freek Verheugt

Artificial intelligence helps pick up AF in ECG acquired during normal sinus rhythm

Literature - Aug. 14, 2019 - Attia Z et al., - The Lancet 2019

Factor Xa inhibitor effective and safe in AF patients with liver disease

Literature - July 23, 2019 - Qamar A, et al. - J Am Coll Cardiol 2019

CV Inflammation

CRP not only related to recurrent CV events, but also to cancer in patients with stable CVD

Literature - Sep. 11, 2019 - Van ’t Klooster CC et al. - Eur Heart J 2019

Understanding and managing obesity-related HFpEF

10' education - July 22, 2019 - Milton Packer, MD

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019

CVRM

Trunk fat associated with higher, but leg fat with lower CVD risk in normal BMI post-menopausal women

Literature - Sep. 16, 2019 - Chen G-C et al., - Eur Heart J. 2019

Large community-based studies stress the impact of preventive measures

3' education - Sep. 9, 2019 - Paris, France - Prof. Salim Yusuf

CV mortality more common in low-income than in high-income countries

News - Sep. 3, 2019

Diabetes

CV Safety of DPP-4 inhibitor in T2DM comparable when directly evaluated against SU

News - Sep. 19, 2019

SGLT2 inhibitor improves HF outcomes and CV death in HF patients irrespective of T2DM status

Literature - Sep. 19, 2019

Better glucose control with early combination therapy in patients newly diagnosed with T2DM

News - Sep. 18, 2019

Familial Hypercholesterolemia

FH patients insufficiently treated, reveals global FH registry

News - Sep. 9, 2019

ANGPTL3 antibody halves LDL-c levels in HoFH patients in phase 3 trial

News - Aug. 15, 2019

Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia

5' education - May 24, 2019 - EAS-endorsed Lp(a) satellite meeting - Prof. Børge Nordestgaard, MD

GLP-1 RA & CVD

The science behind vascular and renal benefits of GLP-1 receptor agonists

10' education - June 12, 2019 - ERA-EDTA 2019 - Filip Krag Knop, MD

Clinical outcomes of GLP-1RA in kidney disease: Current evidence and ongoing trials

10' education - July 12, 2019 - ERA-EDTA 2019 - Frederik Persson, MD

Importance of protection and prevention in diabetic cardiorenal disease

10' education - July 12, 2019 - ERA-EDTA 2019 - Prof. John Deanfield, MD

Heart Failure

SGLT2 inhibitor improves HF outcomes and CV death in HF patients irrespective of T2DM status

Literature - Sep. 19, 2019

Early benefit on health status with ARNI treatment in HFrEF patients

Literature - Sep. 17, 2019 - Khariton Y et al.., - JACC: Heart Failure. 2019

Early and sustained vasodilation strategy fails to improve outcomes in acute HF

3' education - Sep. 2, 2019 - Prof. Christian Müller

HFpEF: The essentials to know

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany - Online CME

Slides: HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

Slides (presentation) - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA - Online CME

Hypertension

Oral K+-binding agent enables use of spironolactone in patients with resistant hypertension and CKD

Literature - Sep. 19, 2019 - Agarwal R et al., - The Lancet 2019

Community-wide salt restriction reduces blood pressure and incidence of hypertension

3' education - Sep. 2, 2019 - Paris, France - Prof. Jaime Miranda

Systolic and diastolic hypertension independently associated with CV outcomes

Literature - July 22, 2019 - Flint AC et al. - N Engl J Med 2019

Inflammation Expert Opinions

Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Clinical implications of inhibiting inflammation as risk factor for progression of CVD

5' education - Aug. 27, 2017

Invest in your arteries

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Importance of hypertension in CVD prevention

10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME

The role of lipids in CVD prevention: Lessons learned about statins

10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam, The Netherlands - Online CME

Lipids

Trunk fat associated with higher, but leg fat with lower CVD risk in normal BMI post-menopausal women

Literature - Sep. 16, 2019 - Chen G-C et al., - Eur Heart J. 2019

LDL-c lowering with twice-a-year injection of siRNA against PCSK9: The ORION-11 trial

10' education - Sep. 16, 2019 - Prof. John Kastelein

High Lp(a) levels associate with mortality, through low number of Kringle-IV type 2 repeats

Literature - Sep. 16, 2019 - Langsted A, et al. - Eur Heart J 2019

Lp(a)

High Lp(a) levels associate with mortality, through low number of Kringle-IV type 2 repeats

Literature - Sep. 16, 2019 - Langsted A, et al. - Eur Heart J 2019

New ESC/EAS dyslipidemia guidelines advocate “lower is better” for LDL-c

News - Sep. 1, 2019

Are we ready for prime-time Lp(a) assay standardization?

5' education - May 24, 2019 - EAS-endorsed Lp(a) satellite meeting - Prof. Santica Marcovina

PCSK9

Primary and secondary efficacy endpoints met with siRNA against PCSK9

News - Aug. 27, 2019

LDL-c lowering PCSK9 gene variants associated with lower CV mortality in general population

Literature - July 1, 2019 - Benn M et al. - J Am Coll Cardiol. 2019

Positive phase II trial data with novel anti-PCSK9 agent

3' education - May 29, 2019 - Maastricht, The Netherlands - Prof. Evan Stein, MD

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Key questions addressed

Online-CME - This course consists of 3 separate lectures

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA - Online CME

Novel insights in the management and prognosis of pulmonary hypertension

5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spain - Prof Nazzareno Galiè - Bologna, Italy

Stroke

Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD

3' education - Sep. 9, 2019 - Prof. Ph. Gabriel Steg

Systolic and diastolic hypertension independently associated with CV outcomes

Literature - July 22, 2019 - Flint AC et al. - N Engl J Med 2019

Vitamin D supplementation not associated with reduced major adverse CV events

Literature - July 1, 2019 - Barbarawi M, et al. - JAMA Cardiol 2019

© 2006 - 2019 pace-cme.org - About